NDA 216483 · Alembic Therap
Pivya
Pivmecillinam Hydrochloride · Oral
Priority reviewLast checked: Nov 20, 2026Latest source record: Apr 24, 2024 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2024
Apr 24, 2024
Approved uses
1
Original approval plus efficacy supplements
Registered trials
11
3 Phase 3, 3 recruiting
FAERS reports
188
184 serious, 19 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Oct 10, 2025.
1. INDICATIONS AND USAGE PIVYA is a penicillin class antibacterial indicated for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus . ( 1.1 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of PIVYA and other antibacterial drugs, PIVYA should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.2 ) 1.1 Uncomplicated Urinary Tract Infections PIVYA is indicated for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli (E. coli) , Proteus mirabilis, and Staphylococcus saprophyticus. 1.2 Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of PIVYA and other antibacterial drugs, PIVYA should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Mechanism: PIVYA is an antibacterial drug [see Microbiology ( 12.4 )] .
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
1 products under this application
- PIVYA · PIVMECILLINAM HYDROCHLORIDE EQ 185MG BASE · TABLET, ORAL · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Pivmecillinam" as an intervention, any sponsor and status, largest first.
- Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.Pivotal-lookingCompleted
Radboud University Medical CenterAcademic, hospital or other
NCT03228108 · 1,538 participants · Start Apr 3, 2018 · Primary completion Sep 26, 2021
Drug: Ciprofloxacin; Trimethoprim/Sulfamethoxazole and 2 more · For: Complication; Infection; Prostate Cancer
Sites: 's-Hertogenbosch, Netherlands; Arnhem, Netherlands; Bergen op Zoom, Netherlands · 13 sites in all
- Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.Pivotal-lookingCompleted
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i GurinaAcademic, hospital or other
NCT04959331 · 1,000 participants · Start Nov 2, 2021 · Primary completion Dec 14, 2024
Drug: Fosfomycin Trometamol Salt; Nitrofurantoin and 2 more · For: Urinary Tract Infections
Sites: Calatayud, Spain; Zaragoza, Spain; Calvià, Spain · 33 sites in all
- Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of CarePivotal-lookingRecruiting
Uppsala UniversityAcademic, hospital or other
NCT07236944 · 560 participants (planned) · Start Dec 2025 · Primary completion Mar 2029
Drug: Pivmecillinam; Standard of Care (Investigator Choice) · For: Febrile Urinary Tract Infection
Sites: Haukeland, Norway; Oslo, Norway; Borås, Sweden · 13 sites in all
- Ibuprofen Versus Mecillinam for Uncomplicated CystitisPivotal-lookingCompleted
University of OsloAcademic, hospital or other
NCT01849926 · 383 participants · Start Apr 2013 · Primary completion Jul 2016
Drug: Ibuprofen; Mecillinam · For: Acute Cystitis (Excl in Pregnancy)
Sites: Oslo, Norway
- Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIsPivotal-lookingRecruiting
Lund UniversityAcademic, hospital or other
NCT05224401 · 330 participants (planned) · Start May 29, 2023 · Primary completion Sep 1, 2027
Drug: Pivmecillinam and amoxicillin/clavulanic acid; Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility · For: Urinary Tract Infections; Bacteremia; Antibiotic Resistant Infection
Sites: Helsingborg, Sweden; Kristianstad, Sweden; Lund, Sweden · 5 sites in all
- Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract InfectionPivotal-lookingCompleted
Benova (Tianjin) Innovative medicine Research Co., Ltd.Academic, hospital or other
NCT05545137 · 299 participants · Start Sep 29, 2022 · Primary completion Feb 5, 2024
Drug: Pivmecillinam hydrochloride tablets; Fosfomycin Tromethamine Granules · For: Uncomplicated Urinary Tract Infection
Sites: Beijing, China; Guangzhou, China; Nanning, China · 10 sites in all
- Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric ProphylaxisPivotal-lookingRecruiting
Copenhagen University Hospital, RigshospitaletAcademic, hospital or other
NCT06709196 · 248 participants (planned) · Start Jan 7, 2025 · Primary completion Jan 2027
Drug: Pivmecillinam; Pivmecillinam and 9 more · For: Cystectomy; Bladder Cancer Requiring Cystectomy; Postoperative Infections and 2 more
Sites: Aalborg, Denmark; Aarhus, Denmark; Copenhagen, Denmark · 5 sites in all
- Prediction and Prevention of Bloodstream Infections After Kidney TransplantationPivotal-lookingNot yet recruiting
Susanne Dam Nielsen, MD, DMScAcademic, hospital or other
NCT07407673 · 180 participants (planned) · Start Jan 1, 2027 · Primary completion Jul 2031
Drug: Pivmecillinam; Placebo · For: Kidney Transplant Infection; Bloodstream Infection; Kidney Transplant and 6 more
Sites: Aarhus, Denmark; Copenhagen, Denmark; Odense, Denmark
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- malaise20
- confusional state19
- urinary incontinence13
- decreased appetite12
- drug interaction12
- diarrhoea11
- headache11
- rash11
- acute kidney injury10
- hyponatraemia9
- balance disorder8
- decreased interest8
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 8 |
| 2014 | 1 |
| 2015 | 7 |
| 2016 | 39 |
| 2017 | 6 |
| 2018 | 17 |
| 2019 | 40 |
| 2020 | 21 |
| 2021 | 39 |
| 2026 | 4 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Clinical and bacteriological effectiveness of three different short-course antibiotic regimens and single-dose fosfomycin for uncomplicated lower urinary tract infections in women (SCOUT): a pragmatic, multicentre, open-label, randomised clinical trial.
Llor C, Monfà R, Garcia-Sangenís A, et al. · Lancet 2026 · Multicenter Study, Pragmatic Clinical Trial
- Pivmecillinam for bacteriuria in pregnancy.
Sanderson P, Menday P · J Antimicrob Chemother 1984 · Clinical Trial, Comparative Study
- Antibiotics for the treatment of dysentery in children.
Traa BS, Walker CL, Munos M, et al. · Int J Epidemiol 2010 · Meta-Analysis, Research Support, N.I.H., Extramural
- Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy.
Guinto VT, De Guia B, Festin MR, et al. · Cochrane Database Syst Rev 2010 · Systematic Review
- Pivmecillinam treatment of chronic urinary tract infection.
Kalager T, Bøe E, Digranes A, et al. · Infection 1978 · Clinical Trial
- Optimal dosage and duration of pivmecillinam treatment for uncomplicated lower urinary tract infections: a systematic review and meta-analysis.
Pinart M, Kranz J, Jensen K, et al. · Int J Infect Dis 2017 · Meta-Analysis, Systematic Review
Sponsor: Alembic Therap
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.